✦ LIBER ✦

S.13.01 Immunotherapy in Alzheimer's disease: is Aβ the right target?

✍ Scribed by D. Boche

Book ID: 118598956
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 63 KB
Volume: 22
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(12)70158-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting β-amyloid pathology in Alzheim

Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy

✍ Roger M. Nitsch; Christoph Hock 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 80 KB

S.25.04 Immunotherapy in Alzheimer's dis

S.25.04 Immunotherapy in Alzheimer's disease – targeting toxic Aβ protofibrils

✍ L. Lannfelt 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Perspectives on future Alzheimer therapi

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease

✍ Lars Lannfelt,Christer Möller,Hans Basun… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 209 KB

IS122 Alzheimer's disease: Aβ-amyloid as

IS122 Alzheimer's disease: Aβ-amyloid as the molecular therapeutic and diagnostic target

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 127 KB

β-secretase as a target for the treatmen

β-secretase as a target for the treatment of Alzheimer's disease

✍ Martin Citron 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 1 views

## Abstract Finding inhibitors of the first step of the amyloid cascade, Aβ~42~ generation, is a major goal of Alzheimer's disease drug development. Two target protease activities, β‐and γ‐secretase, were detected more than 10 years ago but progress in this area has been slow because the enzymes we

Passive anti-amyloid immunotherapy in Al

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

✍ Jens Moreth, Chrystelle Mavoungou, Katharina Schindowski 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 365 KB